Senseonics, a company making an implantable glucose sensor, is working to develop a version of its device that can be worn for one year. The
A special committee of 23andMe’s board of directors said Friday it was “disappointed” in a proposal by CEO Anne Wojcicki to take the company private.
Philips filed a lawsuit Monday against PSN Labs, claiming the company made mistakes in its risk analysis of the soundproofing foam used in Philips’ sleep
Dive Brief: 23andMe CEO Anne Wojcicki filed a preliminary indication of interest to take the DNA testing company private. Wojcicki would pay 40 cents per
By the numbers Q2 revenue: $5.42 billion 8.5% increase year over year Net income: $825 million 11.8% increase year over year Stryker set another record
Arianna Gehan often starts her day by waking up to alerts from the devices she uses to manage her diabetes. “A few days ago, I
Tandem Diabetes Care this year began a full launch of its smallest insulin pump, called Mobi, after the device received clearance from the Food and
By the numbers Q2 revenue: $1 billion 15% increase year-over-year Net income: $143.5 million About 24% increase year-over-year 2024 forecast: Organic sales growth of 11%
Dive Brief: Embecta has hired advisers as it considers a potential sale, the Financial Times reported late Friday. The Parsippany, N.J.-based company makes insulin syringes
Dive Brief: Dental firm Osstem Implant is in advanced talks to acquire Zimvie, Bloomberg reported Wednesday. Osstem submitted a final bid for Zimvie and lined